Drug
Larazotide
Larazotide: highest development phase Phase 2, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| Larazotide Acetate NCT01396213 | Phase 2 | Celiac Disease |
Latest
No recent events.
Follow Larazotide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.